Nomura Holdings’s Biohaven BHVN Stock Holding History

Nomura Holdings’s Portfolio BHVN Stock Details BHVN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-165,000	Closed	-$1.86M	–	1726
2025 Q4	$1.86M	Buy	+165,000	New	+$2.04M	﹤0.01%	1120
2024 Q2	–	Sell	-49,000	Closed	-$2.68M	–	1764
2024 Q1	$2.68M	Buy	+49,000	New	+$2.43M	0.01%	827

Other funds holding BHVN

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

SCM

Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return

Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

IAM

Infinitum Asset Management Fort Lauderdale, Florida $801M AUM 8.83% 1-Year Est. Return

TCM

TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return

RPSM

Royalty Pharma Sub-Manager New York $173M AUM

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Nomura Holdings's BHVN Position: Q1 2026 in Review

Nomura Holdings sold out of Biohaven (BHVN) in Q1 2026, closing a stake of 45,000 shares — an estimated $508K sold.

Nomura Holdings first reported a position in BHVN in Q1 2024 and held it in 3 quarters. The position peaked at $787K in Q1 2024. 275 funds tracked by Wall St. Rank hold BHVN as of Q1 2026.

Nomura Holdings reported no remaining Biohaven position as of Q1 2026 after selling out during the quarter.
Nomura Holdings sold 45,000 Biohaven shares in Q1 2026, an estimated $508K.
Nomura Holdings first reported a position in Biohaven in Q1 2024 and held it in 3 quarters.
Nomura Holdings's Biohaven position peaked at $787K in Q1 2024.
275 funds tracked by Wall St. Rank held Biohaven as of Q1 2026.

Based on Nomura Holdings's 13F filing for Q1 2026, filed 15 May 2026.